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Colorectal  cancer  imaging:  Past,  present
and  future
Colorectal  cancer  is  a  major  public  health  concern.  This  is
clearly  shown  by  the  currently  ongoing  national  screening
program  in  France  and  the  recent  statistics  from  the  French
for  the  post-radiochemotherapy  assessment,  which  has  been
introduced  more  recently  and  remains  largely  dependent  on
individual  surgical  expertise  and  local  practices  [5].o
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rNational  Cancer  Institute  reporting  42,152  new  cases  of  colo-
rectal  cancer  in  2012.  Is  this  the  result  of  a  screening  test
with  very  poor  performances  with  a  sensitivity  of  10%  for
adenomas  and  the  adherence  of  only  one  third  of  solicited
patients?  [1].
In  France,  video  colonoscopy  has  a  pivotal  role  in
screening  and  initial  diagnosis  of  colorectal  cancer  as  it  per-
mits  biopsy  of  any  suspect  lesion  and  resection  of  the  most
detected  lesions.  Virtual  colonoscopy,  as  recommended  by
the  French  National  Health  Authority,  has  indications  that
are  currently  restricted  to  patients  without  risk  factors,
(i.e.,  with  a  relatively  low  pretest  probability)  [2].  This
approach  is  not  the  one  that  is  currently  in  use  in  the  USA
where  virtual  colonoscopy  is  used  for  screening  with  care
and  reimbursement  ensured  by  health  care  systems.  The  role
of  this  technique  appears  to  be  underestimated  in  France  at
least  if  the  United  States  are  considered  as  a  virtuous  model.
Virtual  colonoscopy  is  not  indicated  in  patients  with
conﬁrmed  colon  cancers.  On  the  contrary,  in  conﬁrmed
colon  cancers  computed  tomography  (CT)  colonography  with
water  enema  has  undoubtedly  a  major  role  [2,3].  This  sim-
ple  imaging  technique  is  used  to  conﬁrm  the  presence  of
colon  cancer  in  the  entire  colon,  detect  associated  colonic
and  extra-colonic  disease  and  perform  local  tumour  staging
[2,3].  These  ﬁndings  have  a  major  place  in  the  decision-
making  process  regarding  initial  treatment  and  also  surgical
strategy.
Regarding  rectal  cancer,  the  role  of  imaging  is  limited
to  the  assessment  of  locoregional  and  distant  spread,  as
well  as  the  immediate  and  long-term  post-surgical  eval-
uation  [4]  with  pelvic  magnetic  resonance  (MR)  imaging
playing  a  major  role  as  it  has  gradually  been  adopted
by  clinicians,  at  least  for  the  initial  assessment  of  rectal
tumours.  The  indication,  technique  and  interpretation,  have
become  standardised  at  French  and  European  level,  except
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f  liver  metastases  [6].  For  many  years,  the  detection  of
iver  metastases  by  standard  CT  and  MR  imaging  techniques
as  usually  insufﬁcient  to  meet  the  demands  of  surgeons  as
urgical  reﬁnements  have  more  demands  on  imaging,  includ-
ng  a  detailed  assessment  in  terms  of  size,  number  and
ocation  of  the  hepatic  metastases  present.  The  use  of  rela-
ively  invasive  techniques,  such  as  CT  portography  therefore
ecame  crucial.  Progress  in  CT  scanning  has  enabled  its
erformance  to  reach  that  of  CT  portography  making  intra-
rterial  injection  unnecessary  [7].
More  recently,  MR  imaging  has  begun  to  compete  with  CT
or  the  detection  of  liver  metastases  of  colorectal  cancer
nd  this  examination  is  now  the  preoperative  gold  standard.
lthough  the  injection  of  liver-speciﬁc  contrast  agents  was
ong  necessary,  progress  in  this  ﬁeld  now  makes  it  possible
o  consider  these  products,  which  are  complex  to  use  as  a
elic  of  the  past  [8].  With  the  use  of  gadolinium  chelates,  MR
maging  now  reaches  a  sensitivity  of  about  90%  or  even  more
nd  diffusion-weighted  sequences,  used  in  combination  with
nhanced  sequences  further  improves  this  sensitivity  [9,10].
inally,  it  is  reasonable  to  anticipate  an  improved  perfor-
ance  of  imaging  in  the  detection  of  liver  metastases  of
olorectal  cancer  in  the  near  future  [11,12].
In  this  issue  of  Diagnostic  &  Interventional  Imaging,  sev-
ral  groups  of  authors  give  an  update  on  current  imaging  of
olorectal  cancer.  They  illustrate  as  to  what  extent  modern
maging  has  become  a  major  component  for  the  manage-
ent  of  this  disease.  We  would  like  to  say  the  Alpha  and
mega,  but  for  now,  the  Alpha  (i.e.,  screening)  depends  too
ittle  on  imaging.  It  is  currently  well  admitted  that  screening
emains  the  weak  link  for  an  optimal  management.  Without
eeking  to  draw  hasty  and  controversial  conclusions,  which
therwise  would  be  anything  but  scientiﬁc,  it  is  justiﬁed
nd  even  factual  to  believe  that  imaging  would  improve
tions françaises de radiologie.
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urrently  deﬁcient  screening  practices  if  the  actual  value
f  virtual  colonoscopy  was  recognised.
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